Home LiteratureArticle Details
PMID: 2665440 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S. Research Support, U.S. Gov't, P.H.S. Review

Rationale for the development of an engineered sporozoite malaria vaccine.

Advances in immunology ·Vol. 45 ·1989-00-00 ·Pages 283-334

Nussenzweig V, Nussenzweig RS

Abstract

暂无摘要

MeSH Terms
Animals Antigens, Protozoan/genetics Humans Immunotherapy Malaria/immunology,prevention & control Plasmodium/genetics,growth & development,immunology T-Lymphocytes/immunology Vaccines, Synthetic/therapeutic use
Chemicals
Antigens, Protozoan Vaccines, Synthetic
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Nussenzweig V
Department of Pathology, New York University Medical Center, New York 10016.
Nussenzweig R S
Article Info
Journal
Advances in immunology
Abbr.
Adv Immunol
ISSN
0065-2776
DOI
10.1016/s0065-2776(08)60695-1
Published
1989-00-00
Pages
283-334
Language
English
Region
United States
NLM ID
0370425
Subset
IM
External Links
PubMed source DOI: 10.1016/s0065-2776(08)60695-1 View journal details
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]

Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2